SA
ZVRA icon

Sanctuary Advisors’s Zevra Therapeutics ZVRA Stock Holding History

Sanctuary Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Sell
18,490
-15,971
-46% -$144K ﹤0.01% 2400
2025
Q4 		$309K Buy
34,461
+5,247
+18% +$49.6K ﹤0.01% 1993
2025
Q3 		$278K Buy
29,214
+1,264
+5% +$12.7K ﹤0.01% 2047
2025
Q2 		$246K Buy
27,950
+19
+0.1% +$154 ﹤0.01% 2039
2025
Q1 		$209K Buy
27,931
+7
+0% +$56 ﹤0.01% 2014
2024
Q4 		$224K Hold
27,924
– – ﹤0.01% 2184
2024
Q3 		$268K Sell
27,924
-77,000
-73% -$523K ﹤0.01% 2066
2024
Q2 		$474K Buy
+104,924
New +$497K ﹤0.01% 1677

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return